• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[晚期霍奇金病中的粒细胞黏附及其对抗增殖药物的依赖性]

[Granulocyte adherence in advanced Hodgkin's disease and its dependence on antiproliferative drugs used].

作者信息

Hansz J, Prazmowska-Owczarek B, Nowicka G

出版信息

Acta Haematol Pol. 1979 Jan-Mar;10(1):7-12.

PMID:373364
Abstract

In 36 patients with stage III and IV of Hodgkin's disease granulocyte adherence was investigated. The determinations were carried out in minicolumns filled with nylon fibres. In 13 patients the determinations were repeated 2, 4, 6, 12 and 24 hours after administration of vinblastine and cyclophosphamide. In all patients granulocyte adherence was reduced, by 54.1 +/- 3.5% on the average. The values of adherence in the control group were of the order of 83.7 +/- +/- 4.7%. Administration of antiproliferative drugs reduced further the adherence. The lowest value of it was observed 6 hours after vinblastine and cyclophosphamide administration. After that time the adherence increased gradually reaching the initial level 24 hours after administration of antiproliferative agents. These results suggest that reduced adherence of granulocytes may be an additional cause, besides abnormal immunological reactions, of the impairment of the resistance mechanisms of the organism in advanced stages of Hodgkin's disease.

摘要

对36例Ⅲ期和Ⅳ期霍奇金病患者的粒细胞黏附情况进行了研究。测定在填充尼龙纤维的微型柱中进行。13例患者在给予长春碱和环磷酰胺后2、4、6、12和24小时重复进行测定。所有患者的粒细胞黏附均降低,平均降低54.1±3.5%。对照组的黏附值约为83.7±4.7%。给予抗增殖药物后进一步降低了黏附。在给予长春碱和环磷酰胺后6小时观察到最低值。此后,黏附逐渐增加,在给予抗增殖药物24小时后达到初始水平。这些结果表明,粒细胞黏附降低可能是除异常免疫反应外,霍奇金病晚期机体抵抗机制受损的另一个原因。

相似文献

1
[Granulocyte adherence in advanced Hodgkin's disease and its dependence on antiproliferative drugs used].[晚期霍奇金病中的粒细胞黏附及其对抗增殖药物的依赖性]
Acta Haematol Pol. 1979 Jan-Mar;10(1):7-12.
2
[Granulocyte turnover in advanced Hodgkin's disease].[晚期霍奇金病中的粒细胞更新]
Z Gesamte Inn Med. 1981 Sep 15;36(18):678-80.
3
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.博来霉素、依托泊苷、阿霉素、环磷酰胺、长春新碱、丙卡巴肼和泼尼松方案用于晚期霍奇金淋巴瘤的14天变体:德国霍奇金淋巴瘤研究组的一项试点研究结果
J Clin Oncol. 2003 May 1;21(9):1734-9. doi: 10.1200/JCO.2003.06.028.
4
Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.米托蒽醌、长春碱和洛莫司汀(环己亚硝脲)(MVC):一种用于晚期及预后不良霍奇金淋巴瘤的高效治疗方案。
Cancer J Sci Am. 1998 Jul-Aug;4(4):254-60.
5
[Tissue migration of neutrophil granulocytes in the course of antiproliferative treatment in Hodgkin's disease].[霍奇金病抗增殖治疗过程中中性粒细胞的组织迁移]
Acta Haematol Pol. 1976;7(2):117-22.
6
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].[某放疗诊所霍奇金病治疗结果的回顾性分析]
Strahlenther Onkol. 1994 Sep;170(9):516-23.
7
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.霍奇金淋巴瘤后的继发性闭经受治疗时的年龄、疾病分期、化疗方案以及治疗期间口服避孕药的使用情况影响:来自德国霍奇金淋巴瘤研究组的报告
J Clin Oncol. 2005 Oct 20;23(30):7555-64. doi: 10.1200/JCO.2005.08.138.
8
Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.两种非交叉耐药联合方案(ABVP/LOPP)与COPP加博来霉素治疗晚期霍奇金病的比较。
Neoplasma. 1991;38(6):583-93.
9
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].国际预后评分在晚期霍奇金淋巴瘤预后预测中的应用可行性研究
Ai Zheng. 2006 Aug;25(8):1013-8.
10
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.针对预后不良的儿童霍奇金淋巴瘤,采用风险适应性联合模式疗法(VAMP/COP)及基于反应的累及野放疗。
J Clin Oncol. 2004 Nov 15;22(22):4541-50. doi: 10.1200/JCO.2004.02.139.